The Abramson Cancer Center facilitates interdisciplinary cancer research, education, and patient care. Its299 members are drawn from 41 Departments and eight Schools of the University and have $120,755,622million in research and training (annual direct costs), a 73% increase in the past five years, of which$111,281,669 is peer-reviewed and $56,709,782 is NCI funded (138% increase in the past five years). Thisincludes 20 NIH P01s and seven P50s. John Glick, MD, has served as Director since 1985. ElevenResearch Programs comprise the Cancer Center's three Divisions (Fundamental Research, ClinicalResearch, Cancer Control and Population Sciences). The Cancer Center supports 15 Shared Resources,five of which are new. The development of strong Research Programs and leading-edge Shared Resources,the recruitment of outstanding faculty in areas of priority, and the acquisition of additional research spacehave enabled the Cancer Center to realize its mission. An ongoing strategic planning process identifiesfuture directions, while guiding current activities and resource allocations. A wide range of seminars andretreats as well as interdisciplinary laboratory space are among the ways in which the Cancer Centersucessfully facilitates interaction and collaboration. Developmental Funds are critical to faculty recruitmentand the funding of innovative pilot projects with the potential for peer-reviewed funding, translationalresearch initiatives, and Shared Resources. The Division of Cancer Control and Population Sciences hasbenefited from the recruitment of Caryn Lerman, PhD, as Associate Director and other significant facultyrecruitments. The Clinical Research Division's progress is distinguished by innovative translational researchin all Research Programs and a nationally recognized experimental therapeutics effort. In the basic sciences,leadership changes have led to greater activity in translational research and increased collaborations. TheCancer Center continues to meet Comprehensiveness guidelines, and was last approved in 1999.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA016520-33S2
Application #
7683575
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1997-01-15
Project End
Budget Start
2007-12-01
Budget End
2008-11-30
Support Year
33
Fiscal Year
2008
Total Cost
$250,000
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Garfall, Alfred L; Stadtmauer, Edward A; Hwang, Wei-Ting et al. (2018) Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma. JCI Insight 3:
Jang, Jeong Hoon; Manatunga, Amita K; Taylor, Andrew T et al. (2018) Overall indices for assessing agreement among multiple raters. Stat Med 37:4200-4215
Scheel, John R; Kim, Eunhee; Partridge, Savannah C et al. (2018) MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial. AJR Am J Roentgenol 210:1376-1385
Romero, Sally A D; Brown, Justin C; Bauml, Joshua M et al. (2018) Barriers to physical activity: a study of academic and community cancer survivors with pain. J Cancer Surviv 12:744-752
Hinderer, Christian; Katz, Nathan; Buza, Elizabeth L et al. (2018) Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN. Hum Gene Ther 29:285-298
Li, Jinyang; Byrne, Katelyn T; Yan, Fangxue et al. (2018) Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy. Immunity 49:178-193.e7
Raghunathan, Nirupa Jaya; Korenstein, Deborah; Li, Qing S et al. (2018) Determinants of mobile technology use and smartphone application interest in cancer patients. Cancer Med 7:5812-5819
Hordeaux, Juliette; Wang, Qiang; Katz, Nathan et al. (2018) The Neurotropic Properties of AAV-PHP.B Are Limited to C57BL/6J Mice. Mol Ther 26:664-668
Echevarría-Vargas, Ileabett M; Reyes-Uribe, Patricia I; Guterres, Adam N et al. (2018) Co-targeting BET and MEK as salvage therapy for MAPK and checkpoint inhibitor-resistant melanoma. EMBO Mol Med 10:
Torre, Eduardo; Dueck, Hannah; Shaffer, Sydney et al. (2018) Rare Cell Detection by Single-Cell RNA Sequencing as Guided by Single-Molecule RNA FISH. Cell Syst 6:171-179.e5

Showing the most recent 10 out of 1047 publications